Hospital Cybersecurity Leaders Identify Non-Negotiable Domains to Fund by 2028

December 3, 2025 1:30 PM

A new Black Book™ flash survey of 211 U.S. hospital and health system IT and cybersecurity leaders finds that a small set of cybersecurity domains has become "non-negotiable" for funding between 2026 and 2028 if clinical operations are to remain safe and financially viable.The survey, conducted in November 2025, asked CIOs, CISOs, CTOs, and security leaders to identify their top acquisition and expansion priorities for 2026 and to project which...

Read more

iTolerance, Inc. Releases Next Video in Its Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes

December 3, 2025 10:30 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced the release of the next segment in its Patient Journey video series featuring Kristen and Raul, parent and grandparent, respectively, of a child with Type 1 Diabetes.As part of the segment, Kristen shares about her daughter's Type 1 Diabetes diagnosis, the impact it...

Read more

Medical Care Technologies Inc. (OTC Pink:MDCE) Slashes Costs, Outsmarts Industry Giants with Lean AI Innovation Model

December 3, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to highlight its strategic advantage of operating as a lean, agile company in the competitive AI sector. While many large public companies in the artificial intelligence industry invest hundreds of millions-or even billions-of dollars into infrastructure, proprietary data centers, and in-house development, MDCE has chosen a different path. By leveraging outsourcing for hosting and...

Read more

GAT Sport Launches Zero-Sugar Creatine Chews: 5g of Pure Muscle Energy, No Shaker Needed

December 3, 2025 9:00 AM

GAT Sport (www.gatsport.com), a global leader in performance nutrition trusted by professional athletes, physique buffs and amateur fitness fanatics for more than a quarter-century, today announced the release of its newest innovation Creatine Chews, a zero-sugar, chewable supplement that delivers 5 grams of pure creatine monohydrate per serving for maximum strength, muscle mass, and power on the go.With GAT Sport Creatine Chews, you get a full...

Read more

New Horizon Medical Solutions Announces Exclusive US Partnership with Kent Imaging

December 3, 2025 9:00 AM

New Horizon Medical Solutions (NHMS) today announced it has secured exclusive U.S. distribution rights - across all 48 contiguous states - for Kent Imaging's full lineup of advanced wound-care imaging technologies. This agreement grants NHMS the sole authority to market, promote and distribute Kent Imaging's complete portfolio within the nation's largest clinical systems and care venues.Kent Imaging continues to accelerate its momentum with the...

Read more

What Leads to Gum Recession? Dr. Gallardo Breaks Down Key Contributing Factors

December 3, 2025 8:00 AM

Gum recession is one of the most common oral health concerns among adults, yet many people are unaware of what causes it or why it progresses differently from one person to another. As more patients seek evaluation for symptoms like tooth sensitivity, exposed roots, and changes in their gumline, understanding the underlying factors becomes an important step in protecting oral health. Renowned Miami periodontist Dr. John Paul Gallardo of Gallardo...

Read more

Hoggan Scientific, LLC Receives U.S. Department of Veterans Affairs Federal Supply Schedule (FSS) Contract

December 3, 2025 7:00 AM

Hoggan Scientific, LLC a leading manufacturer and innovator of medical dynamometers, announces that it has been awarded a VA Federal Supply Schedule Contract (FSS 65IIA) under Medical Equipment and Supplies by the U.S. Veteran's Administration. The company's contract number is 36F797D0251, effective 10/15/2025 through 10/14/2030, for its microFET line of diagnostic and evaluation products.The FSS Contract streamlines the procurement process for...

Read more

NEI Announces Grand Opening Presentation: "Women, Menopause, and the Endocannabinoid System"

December 3, 2025 7:00 AM

The Neurodivergent Empowerment Institute (NEI) is proud to feature Heather Reilly Hiemstra as a headline speaker at its Grand Opening Wellness Event on Sunday, December 14, 2025, hosted at NEI's new flagship location: 2200 2nd Ave S, Suite 134, St. Petersburg, FL.Reilly Hiemstra will present "Women, Menopause, Sex, and the Endocannabinoid System", a timely and foundational talk exploring how the endocannabinoid system (ECS) regulates hormonal...

Read more

NEI Highlights Dr. Angela Fisher and Queer Safety Panel at "Celebrate & Connect" Grand Opening Wellness Event

December 3, 2025 6:00 AM

The Neurodivergent Empowerment Institute (NEI) will feature founder Angela Fisher, PhD, in a cornerstone session at its upcoming "Celebrate & Connect" Grand Opening Wellness Event on Sunday, December 14, 2025, at 2200 2nd Ave S, Suite 134, St. Petersburg, FL.Dr. Fisher will participate in and help lead a dedicated panel on queer safety in clinical, educational, and wellness settings, titled: "Queer Safety: Building Truly Affirming Systems for...

Read more

AlzeCure Receives Payment of EU Grant for Phase 2 Clinical Trial with NeuroRestore ACD856 for Alzheimer's Disease

December 3, 2025 4:15 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announced today that the company has received the first payment of a grant of EUR 2.5 million from the European Innovation Council (EIC). The funding will enable a Phase IIa clinical study with the company's innovative drug candidate NeuroRestore ACD856 for...

Read more

Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation

December 3, 2025 4:00 AM

Bioz, Inc., the world's leading AI-powered platform for scientific research and evidence-based product recommendations, is proud to announce the winners of the Bioz Stars Awards 2025, recognizing the most innovative and impactful suppliers of scientific instruments, tools, reagents, and technologies across multidisciplinary scientific research.Now in its newest edition, the Bioz Stars Awards continue to serve as a trusted industry benchmark,...

Read more

President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings

December 3, 2025 3:30 AM

MMJ International Holdings, a pharmaceutical developer of a fully federally compliant, natural cannabinoid pharmaceutical for Huntington's Disease and Multiple Sclerosis, today released a sharply critical analysis of the Drug Enforcement Administration's marijuana research policies-calling them "mathematically impossible, legally contradictory, and scientifically indefensible." For seven years, MMJ has been trapped in a bureaucratic paradox...

Read more

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

December 3, 2025 2:20 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), a clinical-stage biotech developing first-in-class radiopharmaceuticals, has received encouraging feedback from a TypeB pre‑IND meeting with the U.S. Food and Drug Administration (FDA). The discussion addressed key elements of Pentixapharm's planned Phase 3 PANDA study with [ 68 Ga]Ga-PentixaFor, a CXCR4-directed radiodiagnostic intended to significantly improve the diagnostic pathway for...

Read more

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model

December 2, 2025 7:15 PM

Following CMS's announcement of the new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions), Electronic Caregiver, Inc. (ECG) announced its intention to collaborate with eligible Medicare Part B providers and health organizations once CMS releases its list of participating entities in 2026.The ACCESS Model is designed to modernize chronic disease management by incentivizing continuous, tech-enabled care and rewarding...

Read more

Synaptigen Reviews (URGENT REPORT) Does This Sugar-Buildup Fix Really Improve Memory & Cognitive Clarity?

December 2, 2025 5:15 PM

In 2025 and beyond, cognitive supplements are under more scrutiny than ever, especially formulas claiming to clear "sugar buildup" from neurons, a mechanism increasingly discussed in functional medicine circles. Our investigative review of Synaptigen examines whether this gut-to-brain formula offers more than the usual nootropic promises. With rising reports of digital fatigue, disrupted focus, and early memory decline tied to glucose stress in...

Read more

Neurodivergent Empowerment Institute Announces "Celebrate & Connect" Grand Opening Wellness Event

December 2, 2025 4:25 PM

The Neurodivergent Empowerment Institute (NEI), St. Pete's newest integrative healing center, gallery, and event space, is hosting a full-day grand opening wellness event, "Celebrate & Connect," on Sunday, December 14, 2025, from 12:00 PM to 7:00 PM at 2200 2nd Ave S, Suite 134, St. Petersburg, FL.The event features a powerful lineup of talks that weave together a common theme:Rewriting the future of neurodivergent and trauma-informed care...

Read more

NEI Announces Grand Opening Talk: "The Truth About Autism Treatment"

December 2, 2025 3:55 PM

The Neurodivergent Empowerment Institute (NEI), St. Petersburg's newest integrative health center and neurodivergent-affirming clinic, will host a pivotal presentation titled "The Truth About Autism Treatment" as part of its Grand Opening Wellness Event on Sunday, December 14, 2025, at 2200 2nd Ave S, Suite 134, St. Petersburg, FL.Presented by Angela Fisher, PhD, founder of NEI and creator of the Empowerment-Based Integrated Treatment (EBiT)...

Read more

Quietum Plus Reviews (SAFETY REPORT) Is This Ear & Tinnitus Supplement Legit or a Risky Bet in 2025?

December 2, 2025 3:30 PM

In 2025, tinnitus-related anxiety, sound sensitivity, and early hearing decline are rising faster than most people realize, and the demand for safe, non-invasive solutions has never been higher. That's where Quietum Plus enters the conversation: a natural hearing support supplement positioned as a way to nourish auditory nerves, balance stress pathways, and reinforce the brain-ear connection without prescription drugs or invasive devices. But...

Read more

President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution

December 2, 2025 3:25 PM

President Donald Trump now faces one of the most complex drug-policy decisions in modern American history: whether to reschedule marijuana under the Controlled Substances Act (CSA).While industry lobbyists portray rescheduling as a simple political win, the reality is far more explosive - legally, geopolitically, and medically. Behind closed doors, senior officials acknowledge that a broad rescheduling move is not merely a regulatory step, but a...

Read more

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

December 2, 2025 1:45 PM

Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the execution of an exclusive licensing agreement between its wholly owned subsidiary, Exousia Pro Holding Management, LLC, and the University of Central Florida (UCF) concerning its groundbreaking technology for both the diagnosis and treatment of cancer using exosomes.Securing Foundational, Worldwide...

Read more